Survival after brain metastases from breast cancer in the trastuzumab era.
Kirsch
David G
DG
Ledezma
Carlos J
CJ
Mathews
Christina S
CS
Bhan
Atul K
AK
Ancukiewicz
Marek
M
Hochberg
Fred H
FH
Loeffler
Jay S
JS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000401:mortality* / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology*; D003131:Combined Modality Therapy; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab